![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 31/57 | (2006.01) |
A61K 45/06 | (2006.01) | ||
A61P 25/08 | (2006.01) | ||
A61P 25/10 | (2006.01) | ||
A61P 25/12 | (2006.01) | ||
A61P 23/00 | (2006.01) | ||
A61P 43/00 | (2006.01) |
(11) | Number of the document | 2887944 |
(13) | Kind of document | T |
(96) | European patent application number | 13830765.7 |
Date of filing the European patent application | 2013-08-21 | |
(97) | Date of publication of the European application | 2015-07-01 |
(45) | Date of publication and mention of the grant of the patent | 2021-10-06 |
(46) | Date of publication of the claims translation | 2022-01-10 |
(86) | Number | PCT/US2013/056062 |
Date | 2013-08-21 |
(87) | Number | WO 2014/031792 |
Date | 2014-02-27 |
(30) | Number | Date | Country code |
201261691545 P | 2012-08-21 | US | |
201361789491 P | 2013-03-15 | US |
(72) |
REDDY, Kiran , US
KANES, Stephen Jay , US
|
(73) |
Sage Therapeutics, Inc. ,
215 First Street, Cambridge, MA 02142,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Alopregnanolonas, skirtas atsparios epileptinės būklės gydymui |
ALLOPREGNANOLONE FOR TREATING REFRACTORY STATUS EPILEPTICUS |
Payment date | Validity (years) | Amount | |
2024-07-18 | 12 | 289.00 EUR |
2025-08-21 |